NCT04638803View on ClinicalTrials.gov

Microdose Pharmacokinetic Study of PRX-P4-003 In Healthy Volunteers

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 25, 2021

Primary Completion Date

October 30, 2021

Study Completion Date

October 31, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

PRX-P4-003, (-)-FCF

sequential study

Trial Locations (1)

96817

Hawaii Pacific Neuroscience, Honolulu

All Listed Sponsors
lead

Praxis Bioresearch, LLC

INDUSTRY

NCT04638803 - Microdose Pharmacokinetic Study of PRX-P4-003 In Healthy Volunteers | Biotech Hunter | Biotech Hunter